BennyLiu
2023-08-03

$Citius Pharmaceuticals, Inc.(CTXR)$ 2 months delay: might have planned to have all catalyst together:

halo-lido positive meeting for phase-3 trial

Mino-lok data

I/ontak approval

Finally, I/ontak spin-off and buyout Citius

it looked like they planned to have all catalyst together so it can surge in share price before buyout … finally they can negotiate the price for buyout….

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment